NYSE : HCA
HCA Healthcare, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 473.19 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 98.85B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 97.76B |
| Enterprise Value | 149.16B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Dec 15, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 208.89M |
| Shares Outstanding | 208.89M |
| Shares Change (YoY) | -8.70% |
| Shares Change (QoQ) | -2.52% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 64.42% |
| Float | 136.71M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 15.48 |
| Forward PE | 15.30 |
| PS Ratio | 1.24 |
| Forward PS | 1.20 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.31 |
| P/OCF Ratio | 8.72 |
| PEG Ratio | 1.67 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 21.96 |
| EV / Sales | 1.89 |
| EV / EBITDA | 9.42 |
| EV / EBIT | 12.35 |
| EV / FCF | 24.91 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.82 |
| Quick Ratio | 0.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 8.78 |
| Interest Coverage | 5.10 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.23% |
| Return on Invested Capital (ROIC) | 21.36% |
| Return on Capital Employed (ROCE) | 27.60% |
| Weighted Average Cost of Capital (WACC) | 7.98% |
| Revenue Per Employee | $245,941 |
| Profits Per Employee | $21,175 |
| Employee Count | 320,000 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 26.47 |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.02B |
| Effective Tax Rate | 20.60% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +1.12% |
| 50-Day Moving Average | 438.13 |
| 200-Day Moving Average | 444.30 |
| Relative Strength Index (RSI) | 55.72 |
| Average Volume (20 Days) | 1,272,385 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.91M |
| Short Previous Month | 6.48M |
| Short % of Shares Out | 2.35% |
| Short % of Float | 3.59% |
| Short Ratio (days to cover) | 3.70 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 78.70B |
| Gross Profit | 33.65B |
| Operating Income | 12.05B |
| Pretax Income | 9.82B |
| Net Income | 6.78B |
| EBITDA | 15.79B |
| EBIT | 12.05B |
| Earnings Per Share (EPS) | $30.22 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 52.43B |
| Net Cash | -51.41B |
| Net Cash Per Share | -$246.09 |
| Equity (Book Value) | -4.60B |
| Book Value Per Share | -38.30 |
| Working Capital | -3.56B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 11.17B |
| Capital Expenditures | -5.20B |
| Depreciation & Amortization | 3.74B |
| Net Borrowing | 5.77B |
| Free Cash Flow | 5.97B |
| FCF Per Share | $28.59 |
Margins
| Measure | Value |
|---|
| Gross Margin | 42.76% |
| Operating Margin | 15.31% |
| Pretax Margin | 12.48% |
| Profit Margin | 8.61% |
| EBITDA Margin | 20.06% |
| EBIT Margin | 15.31% |
| FCF Margin | 7.59% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $3.12 |
| Dividend Yield | 0.67% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 10.32% |
| FCF Payout Ratio | 10.91% |
| Buyback Yield | 8.70% |
| Shareholder Yield | 9.36% |
| Earnings Yield | 6.46% |
| FCF Yield | 6.13% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $474.52 |
| Price Target Difference | 1.40% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 4.13% |
| EPS Growth Forecast (3Y) | 7.23% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.52 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |